Both in Biotechnology
Cabaletta Bio vs Fate Therapeutics
Over the past year CABA returned −47.4% and FATE returned +75.6%; their daily moves had a correlation of 0.46.
CABA −47.4% FATE +75.6%Growth of $1, one year, split-adjusted
| Metric | CABA | FATE |
|---|---|---|
| Price | $1.42 | $2.09 |
| Market cap | $240.8M | $250.4M |
| Today | 0.00% | +2.45% |
| 1 month | −29.7% | −8.7% |
| 6 months | −61.9% | −8.7% |
| Year to date | −35.2% | +112.7% |
| 1 year | −52.8% | +65.9% |
| Revenue growth (YoY) | — | +9.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −1448.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 38.6× |
| Net cash | $205.1M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 78.7% | 56.4% |
| Short % of float | 27.4% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).